{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:06:34Z","timestamp":1778238394720,"version":"3.51.4"},"reference-count":304,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Regional Development Fund (ERDF)","award":["UIDB\/04539\/2020"],"award-info":[{"award-number":["UIDB\/04539\/2020"]}]},{"name":"European Regional Development Fund (ERDF)","award":["UIDP\/04539\/2020"],"award-info":[{"award-number":["UIDP\/04539\/2020"]}]},{"name":"European Regional Development Fund (ERDF)","award":["LA\/P\/0058\/2020"],"award-info":[{"award-number":["LA\/P\/0058\/2020"]}]},{"name":"European Regional Development Fund (ERDF)","award":["2020.10043.BD"],"award-info":[{"award-number":["2020.10043.BD"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background\/Objectives: Nasal vaccines are a promising strategy for enhancing mucosal immune responses and preventing diseases at mucosal sites by stimulating the secretion of secretory IgA, which is crucial for early pathogen neutralization. However, designing effective nasal vaccines is challenging due to the complex immunological mechanisms in the nasal mucosa, which must balance protection and tolerance against constant exposure to inhaled pathogens. The nasal route also presents unique formulation and delivery hurdles, such as the mucous layer hindering antigen penetration and immune cell access. Methods: This review focuses on cutting-edge approaches to enhance nasal vaccine delivery, particularly those targeting C-type lectin receptors (CLRs) like the mannose receptor and macrophage galactose-type lectin (MGL) receptor. It elucidates the roles of these receptors in antigen recognition and uptake by antigen-presenting cells (APCs), providing insights into optimizing vaccine delivery. Results: While a comprehensive examination of targeted glycoconjugate vaccine development is outside the scope of this study, we provide key examples of glycan-based ligands, such as lactobionic acid and mannose, which can selectively target CLRs in the nasal mucosa. Conclusions: With the rise of new viral infections, this review aims to facilitate the design of innovative vaccines and equip researchers, clinicians, and vaccine developers with the knowledge to enhance immune defenses against respiratory pathogens, ultimately protecting public health.<\/jats:p>","DOI":"10.3390\/pharmaceutics16101308","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T04:29:26Z","timestamp":1728361766000},"page":"1308","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mannose and Lactobionic Acid in Nasal Vaccination: Enhancing Antigen Delivery via C-Type Lectin Receptors"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5147-7226","authenticated-orcid":false,"given":"Mariana","family":"Cola\u00e7o","sequence":"first","affiliation":[{"name":"CNC-UC\u2014Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"CIBB\u2014Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-6754","authenticated-orcid":false,"given":"Maria T.","family":"Cruz","sequence":"additional","affiliation":[{"name":"CNC-UC\u2014Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"CIBB\u2014Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-3307","authenticated-orcid":false,"given":"Lu\u00eds Pereira de","family":"Almeida","sequence":"additional","affiliation":[{"name":"CNC-UC\u2014Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"CIBB\u2014Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2215-5121","authenticated-orcid":false,"given":"Olga","family":"Borges","sequence":"additional","affiliation":[{"name":"CNC-UC\u2014Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"CIBB\u2014Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","article-title":"mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases","volume":"27","author":"Maruggi","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_2","unstructured":"World Health Organization (2023, August 05). Vaccines and Immunization. Available online: https:\/\/www.who.int\/health-topics\/vaccines-and-immunization#tab=tab_1."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jconrel.2022.09.038","article-title":"Mannose in vaccine delivery","volume":"351","author":"Nahar","year":"2022","journal-title":"J. Control Release"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102307","DOI":"10.1016\/j.tube.2023.102307","article-title":"Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant","volume":"139","author":"Duong","year":"2023","journal-title":"Tuberculosis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41541-022-00485-x","article-title":"Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies","volume":"7","author":"Hameed","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cei.13285","article-title":"Mucosal vaccines and technology","volume":"196","author":"Bentley","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines\u2014Fortifying the frontiers","volume":"22","author":"Lavelle","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.vaccine.2023.05.011","article-title":"Advances in intranasal vaccine delivery: A promising non-invasive route of immunization","volume":"41","author":"Kehagia","year":"2023","journal-title":"Vaccine"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Vasquez-Mart\u00ednez, N., Guillen, D., Moreno-Mendieta, S.A., Sanchez, S., and Rodr\u00edguez-Sanoja, R. (2023). The Role of Mucoadhesion and Mucopenetration in the Immune Response Induced by Polymer-Based Mucosal Adjuvants. Polymers, 15.","DOI":"10.3390\/polym15071615"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.vaccine.2008.12.041","article-title":"Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1\/O139 whole cell cholera vaccine: Comparison with other mucosal and systemic responses","volume":"27","author":"Shamsuzzaman","year":"2009","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Song, K.R., Lim, J.K., Park, S.E., Saluja, T., Cho, S., Wartel, T.A., and Lynch, J. (2021). Oral Cholera Vaccine Efficacy and Effectiveness. Vaccines, 9.","DOI":"10.3390\/vaccines9121482"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1128\/CVI.00562-10","article-title":"Antigen-Specific Memory B-Cell Responses in Bangladeshi Adults after One- or Two-Dose Oral Killed Cholera Vaccination and Comparison with Responses in Patients with Naturally Acquired Cholera","volume":"18","author":"Alam","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1128\/CVI.00378-14","article-title":"Critical Analysis of Compositions and Protective Efficacies of Oral Killed Cholera Vaccines","volume":"21","author":"Kabir","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.vaccine.2012.11.012","article-title":"Immune responses and protection in children in developing countries induced by oral vaccines","volume":"31","author":"Qadri","year":"2013","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2018.09.026","article-title":"The Euvichol story\u2014Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships","volume":"36","author":"Odevall","year":"2018","journal-title":"Vaccine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/21645515.2019.1644882","article-title":"An overview of VaxchoraTM, a live attenuated oral cholera vaccine","volume":"16","author":"Saluja","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_18","first-page":"638","article-title":"Vaxchora: The First FDA-Approved Cholera Vaccination in the United States","volume":"42","author":"Mosley","year":"2017","journal-title":"Pharm. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lee, B., Kader, M.A., Colgate, E.R., Carmolli, M., Dickson, D.M., Diehl, S.A., Alam, M., Afreen, S., Mychaleckyj, J.C., and Nayak, U. (2021). Oral rotavirus vaccine shedding as a marker of mucosal immunity. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-01288-1"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00705-015-2439-6","article-title":"Comparative characteristics of the VP7 and VP4 antigenic epitopes of the rotaviruses circulating in Russia (Nizhny Novgorod) and the Rotarix and RotaTeq vaccines","volume":"160","author":"Morozova","year":"2015","journal-title":"Arch. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/CMR.00029-07","article-title":"Rotavirus Vaccines: An Overview","volume":"21","author":"Dennehy","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"eaam5434","DOI":"10.1126\/scitranslmed.aam5434","article-title":"VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans","volume":"9","author":"Nair","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/21645515.2020.1804245","article-title":"Product review of the rotavirus vaccines ROTASIIL, ROTAVAC, and Rotavin-M1","volume":"17","author":"Skansberg","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1870395","DOI":"10.1080\/21645515.2020.1870395","article-title":"Established and new rotavirus vaccines: A comprehensive review for healthcare professionals","volume":"18","author":"Vetter","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(22)00161-X","article-title":"Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: A multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial","volume":"22","author":"Kanungo","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","article-title":"A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"35","author":"Kulkarni","year":"2017","journal-title":"Vaccine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(16)00703-0","article-title":"Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: An open-label randomised controlled trial","volume":"388","author":"Asturias","year":"2016","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1080\/21645515.2017.1288769","article-title":"Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial","volume":"13","author":"Qiu","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1016\/j.vaccine.2005.07.111","article-title":"Vaccines against typhoid fever","volume":"24","author":"Guzman","year":"2006","journal-title":"Vaccine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.vaccine.2014.01.001","article-title":"Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh","volume":"32","author":"Bhuiyan","year":"2014","journal-title":"Vaccine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/j.drudis.2021.07.021","article-title":"Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management","volume":"26","author":"Chavda","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.1128\/JVI.01460-06","article-title":"Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza Vaccines","volume":"80","author":"He","year":"2006","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live Attenuated Influenza Vaccine (FluMist\u00ae; Fluenz\u2122)","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4161\/hv.22317","article-title":"A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac\u00ae) in India","volume":"9","author":"Kulkarni","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1016\/j.vaccine.2011.04.119","article-title":"A pandemic influenza vaccine in India: From strain to sale within 12 months","volume":"29","author":"Dhere","year":"2011","journal-title":"Vaccine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S2213-2600(19)30086-4","article-title":"Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: An open-label, observational, phase 4 study","volume":"7","author":"Lindsey","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sekiya, T., Ohno, M., Nomura, N., Handabile, C., Shingai, M., Jackson, D.C., Brown, L.E., and Kida, H. (2021). Selecting and Using the Appropriate Influenza Vaccine for Each Individual. Viruses, 13.","DOI":"10.3390\/v13060971"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41541-023-00717-8","article-title":"Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin\u00ae)","volume":"8","author":"Singh","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wang, F., Huang, B., Deng, Y., Zhang, S., Liu, X., Wang, L., Liu, Q., Zhao, L., Tang, L., and Wang, W. (2023). Neutralizing antibody levels associated with injectable and aerosolized Ad5-nCoV boosters and BA.2 infection. BMC Med., 21.","DOI":"10.1186\/s12916-023-02942-3"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Pilapitiya, D., Wheatley, A.K., and Tan, H.-X. (2023). Mucosal vaccines for SARS-CoV-2: Triumph of hope over experience. eBioMedicine, 92.","DOI":"10.1016\/j.ebiom.2023.104585"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Li, Y.-D., Chi, W.-Y., Su, J.-H., Ferrall, L., Hung, C.-F., and Wu, T.C. (2020). Coronavirus vaccine development: From SARS and MERS to COVID-19. J. Biomed. Sci., 27.","DOI":"10.1186\/s12929-020-00695-2"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.copbio.2007.10.010","article-title":"Replicating and non-replicating viral vectors for vaccine development","volume":"18","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Bashiri, S., Koirala, P., Toth, I., and Skwarczynski, M. (2020). Carbohydrate Immune Adjuvants in Subunit Vaccines. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12100965"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Shi, J., Zhao, Y., Peng, M., Zhu, S., Wu, Y., Ji, R., and Shen, C. (2023). Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2. Vaccines, 11.","DOI":"10.3390\/vaccines11040713"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Thakur, A., and Foged, C. (2020). Nanoparticles for mucosal vaccine delivery. Nanoengineered Biomaterials for Advanced Drug Delivery, Elsevier.","DOI":"10.1016\/B978-0-08-102985-5.00025-5"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.imlet.2019.10.013","article-title":"Mucosal vaccines: Strategies and challenges","volume":"217","author":"Li","year":"2020","journal-title":"Immunol. Lett."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ramvikas, M., Arumugam, M., Chakrabarti, S.R., and Jaganathan, K.S. (2017). Nasal Vaccine Delivery. Micro and Nanotechnology in Vaccine Development, William Andrew Publishing.","DOI":"10.1016\/B978-0-323-39981-4.00015-4"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Prasher, P., Sharma, M., Singh, S.K., Gulati, M., Jha, N.K., Gupta, P.K., Gupta, G., Chellappan, D.K., Zacconi, F., and de Jesus Andreoli Pinto, T. (2022). Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems. Chem.-Biol. Interact., 365.","DOI":"10.1016\/j.cbi.2022.110048"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.addr.2017.09.020","article-title":"Chemical modification of drug molecules as strategy to reduce interactions with mucus","volume":"124","author":"Martins","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/jox11030007","article-title":"The Central Role of Cytochrome P450 in Xenobiotic Metabolism\u2014A Brief Review on a Fascinating Enzyme Family","volume":"11","author":"Esteves","year":"2021","journal-title":"J. Xenobiotics"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Feng, F., Wen, Z., Chen, J., Yuan, Y., Wang, C., and Sun, C. (2022). Strategies to Develop a Mucosa-Targeting Vaccine against Emerging Infectious Diseases. Viruses, 14.","DOI":"10.3390\/v14030520"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2217\/nnm-2017-0015","article-title":"Recent developments in nanocarrier-aided mucosal vaccination","volume":"12","author":"Kammona","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1586\/erv.12.31","article-title":"Mucosal immunity and nasal influenza vaccination","volume":"11","author":"Rose","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/apm.12351","article-title":"Mucosal vaccines: A paradigm shift in the development of mucosal adjuvants and delivery vehicles","volume":"123","author":"Srivastava","year":"2015","journal-title":"Apmis"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"118813","DOI":"10.1016\/j.ijpharm.2019.118813","article-title":"Nasal route for vaccine and drug delivery: Features and current opportunities","volume":"572","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the immune response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lee, P.-T., Yamamoto, F.Y., Low, C.-F., Loh, J.-Y., and Chong, C.-M. (2021). Gut Immune System and the Implications of Oral-Administered Immunoprophylaxis in Finfish Aquaculture. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.773193"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s13238-015-0164-2","article-title":"Intranasal and oral vaccination with protein-based antigens: Advantages, challenges and formulation strategies","volume":"6","author":"Wang","year":"2015","journal-title":"Protein Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000489405","article-title":"Mucosal Immune Response in Nasal-Associated Lymphoid Tissue upon Intranasal Administration by Adjuvants","volume":"10","author":"Takaki","year":"2018","journal-title":"J. Innate Immun."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Nian, X., Zhang, J., Huang, S., Duan, K., Li, X., and Yang, X. (2022). Development of Nasal Vaccines and the Associated Challenges. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14101983"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41385-020-00359-2","article-title":"The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection","volume":"14","author":"Gallo","year":"2021","journal-title":"Mucosal Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.virol.2005.10.005","article-title":"Genetic mapping of the cold-adapted phenotype of B\/Ann Arbor\/1\/66, the master donor virus for live attenuated influenza vaccines (FluMist\u00ae)","volume":"345","author":"Chen","year":"2006","journal-title":"Virology"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Costa, A., and Andrade, F. (2016). Tissue-based in vitro and ex vivo models for pulmonary permeability studies. Concepts and Models for Drug Permeability Studies, Woodhead Publishing.","DOI":"10.1016\/B978-0-08-100094-6.00015-8"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/path.4843","article-title":"Motile and non-motile cilia in human pathology: From function to phenotypes","volume":"241","author":"Mitchison","year":"2017","journal-title":"J. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Shrewsbury, S.B. (2023). The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and \u201cNose-to-Brain\u201d. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15061720"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Crowe, T.P., and Hsu, W.H. (2022). Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14030629"},{"key":"ref_67","unstructured":"Masters, K.G., Zezoff, D., and Lasrado, S. (2023). Anatomy, Head and Neck, Tonsils, StatPearls."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.molmed.2022.10.009","article-title":"Nasal vaccines: Solutions for respiratory infectious diseases","volume":"29","author":"Fujihashi","year":"2023","journal-title":"Trends Mol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Dillon, A., and Lo, D.D. (2019). M Cells: Intelligent Engineering of Mucosal Immune Surveillance. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01499"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000324590","article-title":"Mucosal Immune Barrier and Antigen-Presenting System in Human Nasal Epithelial Cells","volume":"Volume 72","author":"Himi","year":"2011","journal-title":"Recent Advances in Tonsils and Mucosal Barriers of the Upper Airways"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nri2322","article-title":"The regulation of IgA class switching","volume":"8","author":"Cerutti","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Rosales-Mendoza, S., and Gonz\u00e1lez-Ortega, O. (2019). The Mucosal Immune System: An Outlook for Nanovaccines Development. Nanovaccines: An Innovative Technology to Fight Human and Animal Diseases, Springer.","DOI":"10.1007\/978-3-030-31668-6"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"de Sousa-Pereira, P., and Woof, J.M. (2019). IgA: Structure, Function, and Developability. Antibodies, 8.","DOI":"10.3390\/antib8040057"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/imr.13014","article-title":"Know your enemy or find your friend?\u2014Induction of IgA at mucosal surfaces","volume":"303","author":"Bemark","year":"2021","journal-title":"Immunol. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/immuno2040036","article-title":"Harnessing Nasal Immunity with IgA to Prevent Respiratory Infections","volume":"2","author":"Joseph","year":"2022","journal-title":"Immuno"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Corth\u00e9sy, B. (2013). Multi-Faceted Functions of Secretory IgA at Mucosal Surfaces. Front. Immunol., 4.","DOI":"10.3389\/fimmu.2013.00185"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nri3322","article-title":"New concepts in the generation and functions of IgA","volume":"12","author":"Pabst","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4049\/jimmunol.1601775","article-title":"Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems","volume":"199","author":"Boyaka","year":"2017","journal-title":"J. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.immuni.2018.08.011","article-title":"IgA Responses to Microbiota","volume":"49","author":"Bunker","year":"2018","journal-title":"Immunity"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Bates, J.T. (2022). Na\u00efve CD4+ T Cell Activation in the Nasal-Associated Lymphoid Tissue following Intranasal Immunization with a Flagellin-Based Subunit Vaccine. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415572"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s41232-018-0072-y","article-title":"M cell-dependent antigen uptake on follicle-associated epithelium for mucosal immune surveillance","volume":"38","author":"Nakamura","year":"2018","journal-title":"Inflamm. Regen."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/mi.2007.9","article-title":"Terminology: Nomenclature of mucosa-associated lymphoid tissue","volume":"1","author":"Brandtzaeg","year":"2008","journal-title":"Mucosal Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Patente, T.A., Pinho, M.P., Oliveira, A.A., Evangelista, G.C.M., Bergami-Santos, P.C., and Barbuto, J.A.M. (2019). Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.03176"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"11230","DOI":"10.1039\/C9RA00818G","article-title":"Properties of immature and mature dendritic cellshenotype, morphology, phagocytosis, and migration","volume":"9","author":"Kim","year":"2019","journal-title":"RSC Adv."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Hoober, J.K., Eggink, L.L., and Cote, R. (2019). Stories from the Dendritic Cell Guardhouse. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02880"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Embgenbroich, M., and Burgdorf, S. (2018). Current Concepts of Antigen Cross-Presentation. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01643"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nri2173","article-title":"Dendritic-cell immunotherapy: From ex vivo loading to in vivo targeting","volume":"7","author":"Tacken","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"Steinman","year":"2007","journal-title":"Nature"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/cr.2016.157","article-title":"Dendritic cell-based immunotherapy","volume":"27","author":"Sabado","year":"2016","journal-title":"Cell Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Hong, W., Yang, B., He, Q., Wang, J., and Weng, Q. (2022). New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.841687"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Brandum, E.P., J\u00f8rgensen, A.S., Rosenkilde, M.M., and Hjort\u00f8, G.M. (2021). Dendritic Cells and CCR7 Expression: An Important Factor for Autoimmune Diseases, Chronic Inflammation, and Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158340"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Tavasolian, F., Pastrello, C., Ahmed, Z., Jurisica, I., and Inman, R.D. (2023). Vesicular traffic-mediated cell-to-cell signaling at the immune synapse in Ankylosing Spondylitis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1102405"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Hivroz, C., and Saitakis, M. (2016). Biophysical Aspects of T Lymphocyte Activation at the Immune Synapse. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00046"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4 T cells: Fates, functions, and faults","volume":"112","author":"Zhu","year":"2008","journal-title":"Blood"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Ulivieri, C., and Baldari, C. (2017). Regulation of T Cell Activation and Differentiation by Extracellular Vesicles and Their Pathogenic Role in Systemic Lupus Erythematosus and Multiple Sclerosis. Molecules, 22.","DOI":"10.3390\/molecules22020225"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-022-00763-8","article-title":"The roles of extracellular vesicles in the immune system","volume":"23","author":"Buzas","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/imm.12451","article-title":"Tissue-resident macrophages: Then and now","volume":"144","author":"Davies","year":"2015","journal-title":"Immunology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cmi.12580","article-title":"Macrophages: Sentinels and regulators of the immune system","volume":"18","author":"Franken","year":"2016","journal-title":"Cell. Microbiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/eji.202048881","article-title":"The expanding world of tissue-resident macrophages","volume":"51","author":"Jenkins","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ni.2705","article-title":"Tissue-resident macrophages","volume":"14","author":"Davies","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nri3920","article-title":"Regulation of macrophage development and function in peripheral tissues","volume":"15","author":"Lavin","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ajpath.2015.09.020","article-title":"The Role of the Fibroblast in Inflammatory Upper Airway Conditions","volume":"186","author":"Ball","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Wu, M.-Y., and Lu, J.-H. (2019). Autophagy and Macrophage Functions: Inflammatory Response and Phagocytosis. Cells, 9.","DOI":"10.3390\/cells9010070"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1084\/jem.20180314","article-title":"Macrophage-specific MHCII expression is regulated by a remote Ciita enhancer controlled by NFAT5","volume":"215","author":"Tellechea","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"9653","DOI":"10.3748\/wjg.v20.i29.9653","article-title":"Intestinal antigen-presenting cells in mucosal immune homeostasis: Crosstalk between dendritic cells, macrophages and B-cells","volume":"20","author":"Mann","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.yexcr.2014.10.015","article-title":"Macrophages enhance tumor-derived autophagosomes (DRibbles)-induced B cells activation by TLR4\/MyD88 and CD40\/CD40L","volume":"331","author":"Zhou","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Anfray, C., Ummarino, A., And\u00f3n, F.T., and Allavena, P. (2019). Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses. Cells, 9.","DOI":"10.3390\/cells9010046"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Atri, C., Guerfali, F., and Laouini, D. (2018). Role of Human Macrophage Polarization in Inflammation during Infectious Diseases. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061801"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Hamilton, T.A., Zhao, C., Pavicic, P.G., and Datta, S. (2014). Myeloid Colony-Stimulating Factors as Regulators of Macrophage Polarization. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00554"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0400983101","article-title":"Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria","volume":"101","author":"Verreck","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1189\/jlb.0105015","article-title":"Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-\u03b3- and CD40L-mediated costimulation","volume":"79","author":"Verreck","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Xu, N., Tang, X.-H., Pan, W., Xie, Z.-M., Zhang, G.-F., Ji, M.-H., Yang, J.-J., Zhou, M.-T., and Zhou, Z.-Q. (2017). Spared Nerve Injury Increases the Expression of Microglia M1 Markers in the Prefrontal Cortex of Rats and Provokes Depression-like Behaviors. Front. Neurosci., 11.","DOI":"10.3389\/fnins.2017.00209"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"948098","DOI":"10.1155\/2012\/948098","article-title":"Macrophages in Tumor Microenvironments and the Progression of Tumors","volume":"2012","author":"Hao","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41577-023-00848-y","article-title":"Tissue-specific macrophages: How they develop and choreograph tissue biology","volume":"23","author":"Mass","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Arango Duque, G., and Descoteaux, A. (2014). Macrophage Cytokines: Involvement in Immunity and Infectious Diseases. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00491"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12967-017-1141-8","article-title":"Immune modulation of some autoimmune diseases: The critical role of macrophages and neutrophils in the innate and adaptive immunity","volume":"15","author":"Navegantes","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Yao, Y., Xu, X.-H., and Jin, L. (2019). Macrophage Polarization in Physiological and Pathological Pregnancy. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00792"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Gharavi, A.T., Hanjani, N.A., Movahed, E., and Doroudian, M. (2022). The role of macrophage subtypes and exosomes in immunomodulation. Cell. Mol. Biol. Lett., 27.","DOI":"10.1186\/s11658-022-00384-y"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/JLB.3RU1018-378RR","article-title":"M2b macrophage polarization and its roles in diseases","volume":"106","author":"Wang","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"7835284","DOI":"10.1155\/2020\/7835284","article-title":"The Role of T Cells and Macrophages in Asthma Pathogenesis: A New Perspective on Mutual Crosstalk","volume":"2020","author":"Zhu","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Pastore, M., Grimaudo, S., Pipitone, R.M., Lori, G., Raggi, C., Petta, S., and Marra, F. (2019). Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated with Nonalcoholic Fatty Liver Disease. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00604"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Cheng, H., Wang, Z., Fu, L., and Xu, T. (2019). Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00421"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Otsuka, M., Egawa, G., and Kabashima, K. (2018). Uncovering the Mysteries of Langerhans Cells, Inflammatory Dendritic Epidermal Cells, and Monocyte-Derived Langerhans Cell-Like Cells in the Epidermis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01768"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Zanna, M.Y., Yasmin, A.R., Omar, A.R., Arshad, S.S., Mariatulqabtiah, A.R., Nur-Fazila, S.H., and Mahiza, M.I.N. (2021). Review of Dendritic Cells, Their Role in Clinical Immunology, and Distribution in Various Animal Species. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158044"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Lutz, M.B., Strobl, H., Schuler, G., and Romani, N. (2017). GM-CSF Monocyte-Derived Cells and Langerhans Cells as Part of the Dendritic Cell Family. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01388"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"West, H.C., and Bennett, C.L. (2018). Redefining the Role of Langerhans Cells as Immune Regulators within the Skin. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01941"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.it.2017.06.008","article-title":"Langerhans Cells\u2014The Macrophage in Dendritic Cell Clothing","volume":"38","author":"Doebel","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ni.3270","article-title":"CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation","volume":"16","author":"Price","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-417028-5.00001-6","article-title":"Ontogeny and Functional Specialization of Dendritic Cells in Human and Mouse","volume":"120","author":"Haniffa","year":"2013","journal-title":"Adv. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.it.2010.08.006","article-title":"In vivo function of Langerhans cells and dermal dendritic cells","volume":"31","author":"Kaplan","year":"2010","journal-title":"Trends Immunol."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"De Monte, A., Olivieri, C.-V., Vitale, S., Bailleux, S., Castillo, L., Giordanengo, V., Maryanski, J.L., Segura, E., and Doglio, A. (2016). CD1c-Related DCs that Express CD207\/Langerin, but Are Distinguishable from Langerhans Cells, Are Consistently Present in Human Tonsils. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00197"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Carenza, C., Calcaterra, F., Oriolo, F., Di Vito, C., Ubezio, M., Della Porta, M.G., Mavilio, D., and Della Bella, S. (2019). Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01325"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41590-019-0420-3","article-title":"Plasmacytoid dendritic cells develop from Ly6D+ lymphoid progenitors distinct from the myeloid lineage","volume":"20","author":"Dress","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ircmb.2019.07.004","article-title":"Dendritic cell subsets and locations","volume":"348","author":"Balan","year":"2019","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.immuni.2012.10.016","article-title":"Conventional and Monocyte-Derived CD11b+ Dendritic Cells Initiate and Maintain T Helper 2 Cell-Mediated Immunity to House Dust Mite Allergen","volume":"38","author":"Plantinga","year":"2013","journal-title":"Immunity"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/icb.2016.104","article-title":"Heterogeneity, functional specialization and differentiation of monocyte-derived dendritic cells","volume":"95","author":"Chow","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Huber, A., Dammeijer, F., Aerts, J.G.J.V., and Vroman, H. (2018). Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02804"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40425-019-0580-6","article-title":"The clinical application of cancer immunotherapy based on naturally circulating dendritic cells","volume":"7","author":"Bol","year":"2019","journal-title":"J. ImmunoTherapy Cancer"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.20061660","article-title":"Plasmacytoid dendritic cells prime IL-10\u2013producing T regulatory cells by inducible costimulator ligand","volume":"204","author":"Ito","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1002\/cpz1.50","article-title":"Phenotypic and Functional Study of Human Plasmacytoid Dendritic Cells","volume":"1","author":"Li","year":"2021","journal-title":"Curr. Protoc."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: A unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Cueto, F.J., del Fresno, C., and Sancho, D. (2020). DNGR-1, a Dendritic Cell-Specific Sensor of Tissue Damage That Dually Modulates Immunity and Inflammation. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.03146"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Calmeiro, J., Carrascal, M.A., Tavares, A.R., Ferreira, D.A., Gomes, C., Falc\u00e3o, A., Cruz, M.T., and Neves, B.M. (2020). Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12020158"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"eaav3942","DOI":"10.1126\/sciimmunol.aav3942","article-title":"IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer","volume":"5","author":"Hubert","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1084\/jem.20092720","article-title":"Mouse CD8\u03b1+ DCs and human BDCA3+ DCs are major producers of IFN-\u03bb in response to poly IC","volume":"207","author":"Lauterbach","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Minoda, Y., Virshup, I., Leal Rojas, I., Haigh, O., Wong, Y., Miles, J.J., Wells, C.A., and Radford, K.J. (2017). Human CD141+ Dendritic Cell and CD1c+ Dendritic Cell Undergo Concordant Early Genetic Programming after Activation in Humanized Mice In Vivo. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01419"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev-immunol-032713-120204","article-title":"Transcriptional Control of Dendritic Cell Development","volume":"34","author":"Murphy","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Heger, L., Hofer, T.P., Bigley, V., de Vries, I.J.M., Dalod, M., Dudziak, D., and Ziegler-Heitbrock, L. (2020). Subsets of CD1c+ DCs: Dendritic Cell Versus Monocyte Lineage. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.559166"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1182\/blood-2013-04-495424","article-title":"Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses","volume":"122","author":"Nizzoli","year":"2013","journal-title":"Blood"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1158\/0008-5472.CAN-15-1695","article-title":"Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines","volume":"76","author":"Bakdash","year":"2016","journal-title":"Cancer Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/cyto.b.21332","article-title":"CD1c(+) myeloid dendritic cells in myeloid neoplasia","volume":"90","author":"Meyerson","year":"2015","journal-title":"Cytom. Part B Clin. Cytom."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.4049\/jimmunol.1600193","article-title":"Human Blood CD1c+ Dendritic Cells Encompass CD5high and CD5low Subsets That Differ Significantly in Phenotype, Gene Expression, and Functions","volume":"198","author":"Yin","year":"2017","journal-title":"J. Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.cell.2019.09.035","article-title":"Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity","volume":"179","author":"Brown","year":"2019","journal-title":"Cell"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.humimm.2021.08.007","article-title":"Pattern recognition receptor expression and maturation profile of dendritic cell subtypes in human tonsils and lymph nodes","volume":"82","author":"Askmyr","year":"2021","journal-title":"Hum. Immunol."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Solano-G\u00e1lvez, S., Tovar-Torres, S., Tron-G\u00f3mez, M., Weiser-Smeke, A., \u00c1lvarez-Hern\u00e1ndez, D., Franyuti-Kelly, G., Tapia-Moreno, M., Ibarra, A., Guti\u00e9rrez-Kobeh, L., and V\u00e1zquez-L\u00f3pez, R. (2018). Human Dendritic Cells: Ontogeny and Their Subsets in Health and Disease. Med. Sci., 6.","DOI":"10.3390\/medsci6040088"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1586\/1744666X.2014.912561","article-title":"Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy","volume":"10","author":"Bakdash","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Reinartz, S., Tongeren, J., Egmond, D., Groot, E., Fokkens, W., and Drunen, C. (2016). Dendritic Cell Subsets in Oral Mucosa of Allergic and Healthy Subjects. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154409"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/all.12770","article-title":"Dendritic cells revisited in human allergic rhinitis and asthma","volume":"71","author":"Froidure","year":"2016","journal-title":"Allergy"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/mi.2017.8","article-title":"Development of conventional dendritic cells: From common bone marrow progenitors to multiple subsets in peripheral tissues","volume":"10","author":"Sichien","year":"2017","journal-title":"Mucosal Immunol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbamem.2013.04.018","article-title":"EpCAM: Structure and function in health and disease","volume":"1828","author":"Schnell","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1189\/jlb.1MA0316-131R","article-title":"Differential regulation of CD103 (\u03b1E integrin) expression in human dendritic cells by retinoic acid and Toll-like receptor ligands","volume":"101","author":"Roe","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/mi.2014.135","article-title":"Phenotype and function of nasal dendritic cells","volume":"8","author":"Lee","year":"2015","journal-title":"Mucosal Immunol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","article-title":"Approaching the Asymptote? Evolution and Revolution in Immunology","volume":"Volume 54","author":"Janeway","year":"1989","journal-title":"Cold Spring Harbor Symposia on Quantitative Biology"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0264-410X(03)00199-3","article-title":"Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity","volume":"21","author":"Mantovani","year":"2003","journal-title":"Vaccine"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/41131","article-title":"A human homologue of the Drosophila Toll protein signals activation of adaptive immunity","volume":"388","author":"Medzhitov","year":"1997","journal-title":"Nature"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"14560","DOI":"10.1074\/jbc.274.21.14560","article-title":"Nod1, an Apaf-1-like Activator of Caspase-9 and Nuclear Factor-\u03baB","volume":"274","author":"Inohara","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"9914854","DOI":"10.1155\/2021\/9914854","article-title":"Toll-like Receptors: General Molecular and Structural Biology","volume":"2021","author":"Behzadi","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","article-title":"Use of defined TLR ligands as adjuvants within human vaccines","volume":"239","author":"Duthie","year":"2010","journal-title":"Immunol. Rev."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.4049\/jimmunol.1502599","article-title":"TLR10 Is a Negative Regulator of Both MyD88-Dependent and -Independent TLR Signaling","volume":"196","author":"Jiang","year":"2016","journal-title":"J. Immunol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.0901888","article-title":"Human TLRs 10 and 1 Share Common Mechanisms of Innate Immune Sensing but Not Signaling","volume":"184","author":"Guan","year":"2010","journal-title":"J. Immunol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1016-8478(23)07382-X","article-title":"Pattern-recognition receptor signaling initiated from extracellular, membrane, and cytoplasmic space","volume":"23","author":"Lee","year":"2007","journal-title":"Mol. Cells"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1126\/science.1229159","article-title":"Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands","volume":"339","author":"Tanji","year":"2013","journal-title":"Science"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1189\/jlb.0408228","article-title":"Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy","volume":"88","author":"Krummen","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/eji.200324714","article-title":"Identification of a TLR4- and TRIF-dependent activation program of dendritic cells","volume":"34","author":"Weighardt","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.4049\/jimmunol.1401605","article-title":"TRAM Is Required for TLR2 Endosomal Signaling to Type I IFN Induction","volume":"193","author":"Stack","year":"2014","journal-title":"J. Immunol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature01180","article-title":"The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors","volume":"420","author":"Horng","year":"2002","journal-title":"Nature"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-2478(02)00010-X","article-title":"Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-\u03baB, ERK and p38 MAPK signal pathways","volume":"81","author":"An","year":"2002","journal-title":"Immunol. Lett."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jep.2012.10.051","article-title":"Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-\u03baB and MAPKs signaling pathways","volume":"145","author":"Fu","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Luchner, M., Reinke, S., and Milicic, A. (2021). TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020142"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","article-title":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses","volume":"5","author":"Yoneyama","year":"2004","journal-title":"Nat. Immunol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.immuni.2008.07.009","article-title":"Structural Mechanism of RNA Recognition by the RIG-I-like Receptors","volume":"29","author":"Yoneyama","year":"2008","journal-title":"Immunity"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: Their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Benedict, C.A., Eichholz, K., Bru, T., Tran, T.T.P., Fernandes, P., Welles, H., Mennechet, F.J.D., Manel, N., Alves, P., and Perreau, M. (2016). Immune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic Cells. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005871"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"13225","DOI":"10.1074\/jbc.M113.468033","article-title":"Structure of the Absent in Melanoma 2 (AIM2) Pyrin Domain Provides Insights into the Mechanisms of AIM2 Autoinhibition and Inflammasome Assembly","volume":"288","author":"Jin","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS\u2013STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11912-023-01361-0","article-title":"The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy","volume":"25","author":"Hines","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1172\/JCI79915","article-title":"Nanoparticulate STING agonists are potent lymph node\u2013targeted vaccine adjuvants","volume":"125","author":"Hanson","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"104131","DOI":"10.1016\/j.dci.2021.104131","article-title":"Progresses on three pattern recognition receptor families (TLRs, RLRs and NLRs) in teleost","volume":"122","author":"Liao","year":"2021","journal-title":"Dev. Comp. Immunol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molcel.2014.02.018","article-title":"Molecular Basis for Specific Recognition of Bacterial Ligands by NAIP\/NLRC4 Inflammasomes","volume":"54","author":"Tenthorey","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Ohto, U. (2022). Activation and regulation mechanisms of NOD-like receptors based on structural biology. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.953530"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: Mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.abb.2019.02.008","article-title":"NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways","volume":"670","author":"Platnich","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1111\/febs.13014","article-title":"NOD-like receptors interfacing the immune and reproductive systems","volume":"281","author":"Gorp","year":"2014","journal-title":"FEBS J."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"eabe1757","DOI":"10.1126\/scisignal.abe1757","article-title":"Select hyperactivating NLRP3 ligands enhance the TH1- and TH17-inducing potential of human type 2 conventional dendritic cells","volume":"14","author":"Hatscher","year":"2021","journal-title":"Sci. Signal."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1126\/science.aaf3036","article-title":"An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells","volume":"352","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/eji.201646903","article-title":"Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1","volume":"47","author":"Vasquez","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/eji.200737127","article-title":"Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-A and scavenger receptor expressed by endothelial cells-I","volume":"37","author":"Facciponte","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.freeradbiomed.2005.08.039","article-title":"Homocysteine from endothelial cells promotes LDL nitration and scavenger receptor uptake","volume":"40","author":"Griffiths","year":"2006","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/BST0320633","article-title":"Scavenger receptors and heat-shock protein-mediated antigen cross-presentation","volume":"32","author":"Delneste","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<512::AID-IMMU512>3.0.CO;2-Y","article-title":"The macrophage scavenger receptor type A directs modified proteins to antigen presentation","volume":"29","author":"Nicoletti","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nri3515","article-title":"Scavenger receptors in homeostasis and immunity","volume":"13","author":"Canton","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J. Mol. Med."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/eji.201546131","article-title":"A novel \u201ccomplement\u2013metabolism\u2013inflammasome axis\u201d as a key regulator of immune cell effector function","volume":"46","author":"Arbore","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Shokal, U., and Eleftherianos, I. (2017). Evolution and Function of Thioester-Containing Proteins and the Complement System in the Innate Immune Response. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00759"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/imr.12852","article-title":"Complement and human T cell metabolism: Location, location, location","volume":"295","author":"West","year":"2020","journal-title":"Immunol. Rev."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cll.2019.07.006","article-title":"Analysis of the Complement System in the Clinical Immunology Laboratory","volume":"39","author":"Ling","year":"2019","journal-title":"Clin. Lab. Med."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nri3761","article-title":"Complement\u2014Tapping into new sites and effector systems","volume":"14","author":"Kolev","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2019.11.007","article-title":"T Cell Antifungal Immunity and the Role of C-Type Lectin Receptors","volume":"41","author":"Speakman","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Jung, S., Kim, S., Kim, Y., Chung, H., Kim, S., and Yeo, S. (2018). Expression, Distribution, and Role of C-Type Lectin Receptors in the Human and Animal Middle Ear and Eustachian Tube: A Review. Molecules, 23.","DOI":"10.3390\/molecules23040734"},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Mnich, M.E., van Dalen, R., and van Sorge, N.M. (2020). C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00309"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Yan, H., Kamiya, T., Suabjakyong, P., and Tsuji, N.M. (2015). Targeting C-Type Lectin Receptors for Cancer Immunity. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00408"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-018-0087-2","article-title":"CARD\u2013BCL-10\u2013MALT1 signalling in protective and pathological immunity","volume":"19","author":"Ruland","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/cmi.12249","article-title":"Signalling C-Type lectin receptors, microbial recognition and immunity","volume":"16","author":"Hoving","year":"2014","journal-title":"Cell. Microbiol."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Sosa Cuevas, E., Valladeau-Guilemond, J., Mouret, S., Roubinet, B., de Fraipont, F., Landemarre, L., Charles, J., Bendriss-Vermare, N., Chaperot, L., and Aspord, C. (2022). Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1040600"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/eji.201847536","article-title":"C-type lectin receptors of the Dectin-1 clusterhysiological roles and involvement in disease","volume":"49","author":"Tone","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Scur, M., Parsons, B.D., Dey, S., and Makrigiannis, A.P. (2023). The diverse roles of C-type lectin-like receptors in immunity. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1126043"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri2569","article-title":"Signalling through C-type lectin receptors: Shaping immune responses","volume":"9","author":"Geijtenbeek","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.4049\/jimmunol.171.9.4552","article-title":"Cross-Linking of the Mannose Receptor on Monocyte-Derived Dendritic Cells Activates an Anti-Inflammatory Immunosuppressive Program","volume":"171","author":"Chieppa","year":"2003","journal-title":"J. Immunol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/s41467-020-15937-y","article-title":"Engineered niches support the development of human dendritic cells in humanized mice","volume":"11","author":"Anselmi","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11882-023-01067-0","article-title":"C-Type Lectin Receptor Mediated Modulation of T2 Immune Responses to Allergens","volume":"23","author":"Angelina","year":"2023","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"van der Zande, H.J.P., Nitsche, D., Schlautmann, L., Guigas, B., and Burgdorf, S. (2021). The Mannose Receptor: From Endocytic Receptor and Biomarker to Regulator of (Meta)Inflammation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.765034"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1242\/jcs.113.6.1021","article-title":"Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor","volume":"113","author":"Sheikh","year":"2000","journal-title":"J. Cell Sci."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/375151a0","article-title":"The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing","volume":"375","author":"Jiang","year":"1995","journal-title":"Nature"},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Cummings, R.D. (2022). The mannose receptor ligands and the macrophage glycome. Curr. Opin. Struct. Biol., 75.","DOI":"10.1016\/j.sbi.2022.102394"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1432-1033.1994.00375.x","article-title":"Structural Comparison of phospholipase-A2-binding Regions in phospholipase-A2 Receptors from Various Mammals","volume":"225","author":"Higashino","year":"2005","journal-title":"Eur. J. Biochem."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"12156","DOI":"10.1016\/S0021-9258(19)38325-5","article-title":"Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains","volume":"265","author":"Taylor","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1084\/jem.191.7.1117","article-title":"The Cysteine-Rich Domain of the Macrophage Mannose Receptor Is a Multispecific Lectin That Recognizes Chondroitin Sulfates a and B and Sulfated Oligosaccharides of Blood Group Lewisa and Lewisx Types in Addition to the Sulfated N-Glycans of Lutropin","volume":"191","author":"Leteux","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000488539","article-title":"Antifungal Innate Immunity: A Perspective from the Last 10 Years","volume":"10","author":"Salazar","year":"2018","journal-title":"J. Innate Immun."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.lfs.2019.03.062","article-title":"Attributes of alternatively activated (M2) macrophages","volume":"224","author":"Shrivastava","year":"2019","journal-title":"Life Sci."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0021-9258(18)54164-8","article-title":"Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor","volume":"268","author":"Taylor","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Feinberg, H., J\u00e9gouzo, S.A.F., Lasanajak, Y., Smith, D.F., Drickamer, K., Weis, W.I., and Taylor, M.E. (2021). Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J. Biol. Chem., 296.","DOI":"10.1016\/j.jbc.2021.100368"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.it.2004.12.001","article-title":"The mannose receptor: Linking homeostasis and immunity through sugar recognition","volume":"26","author":"Taylor","year":"2005","journal-title":"Trends Immunol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1083\/jcb.92.2.417","article-title":"Mannose-specific endocytosis receptor of alveolar macrophages: Demonstration of two functionally distinct intracellular pools of receptor and their roles in receptor recycling","volume":"92","author":"Tietze","year":"1982","journal-title":"J. Cell Biol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1084\/jem.172.6.1785","article-title":"Molecular characterization of the human macrophage mannose receptor: Demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells","volume":"172","author":"Ezekowitz","year":"1990","journal-title":"J. Exp. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1189\/jlb.0512231","article-title":"The mannose receptor","volume":"92","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"23376","DOI":"10.1074\/jbc.273.36.23376","article-title":"A Functional Soluble Form of the Murine Mannose Receptor Is Produced by Macrophages in Vitro and Is Present in Mouse Serum","volume":"273","author":"Mahoney","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"e210330411","DOI":"10.1073\/pnas.2103304118","article-title":"Soluble mannose receptor induces proinflammatory macrophage activation and metaflammation","volume":"118","author":"Embgenbroich","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.imbio.2008.11.004","article-title":"Influence of the mannose receptor in host immune responses","volume":"214","author":"Gazi","year":"2009","journal-title":"Immunobiology"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.str.2017.11.006","article-title":"Structural Insights into the pH-Dependent Conformational Change and Collagen Recognition of the Human Mannose Receptor","volume":"26","author":"Hu","year":"2018","journal-title":"Structure"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.18632\/oncotarget.14314","article-title":"N-glycosylation converts non-glycoproteins into mannose receptor ligands and reveals antigen-specific T cell responses in vivo","volume":"8","author":"Kreer","year":"2016","journal-title":"Oncotarget"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1137971","article-title":"Distinct Pathways of Antigen Uptake and Intracellular Routing in CD4 and CD8 T Cell Activation","volume":"316","author":"Burgdorf","year":"2007","journal-title":"Science"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"104257","DOI":"10.1016\/j.dci.2021.104257","article-title":"Expression and functional characterization of the mannose receptor (MR) from Nile tilapia (Oreochromis niloticus) in response to bacterial infection","volume":"126","author":"Yin","year":"2022","journal-title":"Dev. Comp. Immunol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","article-title":"Pathways of Antigen Processing","volume":"31","author":"Blum","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Ouyang, A., Wang, H., Su, J., and Liu, X. (2021). Mannose Receptor Mediates the Activation of Chitooligosaccharides on Blunt Snout Bream (Megalobrama amblycephala) Macrophages. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.686846"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Sil, A., Wagener, J., Malireddi, R.K.S., Lenardon, M.D., K\u00f6berle, M., Vautier, S., MacCallum, D.M., Biedermann, T., Schaller, M., and Netea, M.G. (2014). Fungal Chitin Dampens Inflammation through IL-10 Induction Mediated by NOD2 and TLR9 Activation. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004050"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.chom.2009.02.006","article-title":"The Macrophage Mannose Receptor Induces IL-17 in Response to Candida albicans","volume":"5","author":"Marijnissen","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40478-015-0223-1","article-title":"Trichuris suis induces human non-classical patrolling monocytes via the mannose receptor and PKC: Implications for multiple sclerosis","volume":"3","author":"Kooij","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.celrep.2017.09.034","article-title":"M. tuberculosis-Initiated Human Mannose Receptor Signaling Regulates Macrophage Recognition and Vesicle Trafficking by FcR\u03b3-Chain, Grb2, and SHP-1","volume":"21","author":"Rajaram","year":"2017","journal-title":"Cell Rep."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"10649","DOI":"10.1073\/pnas.1605885113","article-title":"Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4","volume":"113","author":"Schuette","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1208\/s12249-019-1526-5","article-title":"Mannose-Modified PLGA Nanoparticles for Sustained and Targeted Delivery in Hepatitis B Virus Immunoprophylaxis","volume":"21","author":"Zhu","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biomaterials.2016.10.047","article-title":"Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine","volume":"113","author":"Shi","year":"2017","journal-title":"Biomaterials"},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Pei, M., Xu, R., Zhang, C., Wang, X., Li, C., and Hu, Y. (2021). Mannose-functionalized antigen nanoparticles for targeted dendritic cells, accelerated endosomal escape and enhanced MHC-I antigen presentation. Colloids Surf. B Biointerfaces, 197.","DOI":"10.1016\/j.colsurfb.2020.111378"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1039\/C8BM00282G","article-title":"Polymer-augmented liposomes enhancing antibiotic delivery against intracellular infections","volume":"6","author":"Su","year":"2018","journal-title":"Biomater. Sci."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41563-018-0256-5","article-title":"Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity","volume":"18","author":"Wilson","year":"2019","journal-title":"Nat. Mater."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biomaterials.2019.03.012","article-title":"Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination","volume":"206","author":"Zhu","year":"2019","journal-title":"Biomaterials"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00253-014-6147-z","article-title":"Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity","volume":"99","author":"Cui","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Zhuang, X., Qi, Y., Wang, M., Yu, N., Nan, F., Zhang, H., Tian, M., Li, C., Lu, H., and Jin, N. (2020). mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice. Vaccines, 8.","DOI":"10.3390\/vaccines8010123"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.colsurfb.2015.01.005","article-title":"Mannosylated and lipid A-incorporating cationic liposomes constituting microneedle arrays as an effective oral mucosal HBV vaccine applicable in the controlled temperature chain","volume":"126","author":"Wang","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Heger, L., Balk, S., L\u00fchr, J.J., Heidkamp, G.F., Lehmann, C.H.K., Hatscher, L., Purbojo, A., Hartmann, A., Garcia-Martin, F., and Nishimura, S.-I. (2018). CLEC10A Is a Specific Marker for Human CD1c+ Dendritic Cells and Enhances Their Toll-Like Receptor 7\/8-Induced Cytokine Secretion. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00744"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3892\/ol.2022.13405","article-title":"CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer","volume":"24","author":"Tang","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbagen.2007.10.017","article-title":"The amino acids involved in the distinct carbohydrate specificities between macrophage galactose-type C-type lectins 1 and 2 (CD301a and b) of mice","volume":"1780","author":"Maenuma","year":"2008","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"19193","DOI":"10.1074\/jbc.M110.113613","article-title":"Distribution and Function of Macrophage Galactose-type C-type Lectin 2 (MGL2\/CD301b)","volume":"285","author":"Aida","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.biochem.1c00009","article-title":"Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to GalNAc and the Tumor-Associated Tn Antigen","volume":"60","author":"Gabba","year":"2021","journal-title":"Biochemistry"},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"Fu, Y.L., and Harrison, R.E. (2021). Microbial Phagocytic Receptors and Their Potential Involvement in Cytokine Induction in Macrophages. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.662063"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1158\/0008-5472.CAN-07-1035","article-title":"Tumor-Associated Tn-MUC1 Glycoform Is Internalized through the Macrophage Galactose-Type C-Type Lectin and Delivered to the HLA Class I and II Compartments in Dendritic Cells","volume":"67","author":"Napoletano","year":"2007","journal-title":"Cancer Res."},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Yu, L.-G., Beatson, R., Maurstad, G., Picco, G., Arulappu, A., Coleman, J., Wandell, H.H., Clausen, H., Mandel, U., and Taylor-Papadimitriou, J. (2015). The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125994"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00262-006-0274-z","article-title":"The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma","volume":"56","author":"Saeland","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_272","doi-asserted-by":"crossref","unstructured":"Zaal, A., Li, R.J.E., L\u00fcbbers, J., Bruijns, S.C.M., Kalay, H., van Kooyk, Y., and van Vliet, S.J. (2020). Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00305"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2021.06.012","article-title":"The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2)","volume":"518","author":"Carasi","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/14728222.2024.2374743","article-title":"The pleiotropic CLEC10A: Implications for harnessing this receptor in the tumor microenvironment","volume":"28","author":"Travecedo","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Napoletano, C., Steentoff, C., Battisti, F., Ye, Z., Rahimi, H., Zizzari, I.G., Dionisi, M., Cerbelli, B., Tomao, F., and French, D. (2020). Investigating Patterns of Immune Interaction in Ovarian Cancerrobing the O-glycoproteome by the Macrophage Galactose-Like C-Type Lectin (MGL). Cancers, 12.","DOI":"10.3390\/cancers12102841"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/glycob\/cwt022","article-title":"Organization of the extracellular portion of the macrophage galactose receptor: A trimeric cluster of simple binding sites for N-acetylgalactosamine","volume":"23","author":"Ouyang","year":"2013","journal-title":"Glycobiology"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"20686","DOI":"10.1074\/jbc.M202104200","article-title":"The Macrophage C-type Lectin Specific for Galactose\/N-Acetylgalactosamine Is an Endocytic Receptor Expressed on Monocyte-derived Immature Dendritic Cells","volume":"277","author":"Higashi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/eji.200636838","article-title":"MGL-mediated internalization and antigen presentation by dendritic cells: A role for tyrosine-5","volume":"37","author":"Aarnoudse","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.4049\/jimmunol.167.10.5767","article-title":"Immature Human Dendritic Cells Express Asialoglycoprotein Receptor Isoforms for Efficient Receptor-Mediated Endocytosis","volume":"167","author":"Valladeau","year":"2001","journal-title":"J. Immunol."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ceb.2011.03.004","article-title":"Endocytic sorting of transmembrane protein cargo","volume":"23","author":"Kelly","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/eji.201142086","article-title":"Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation","volume":"42","author":"Napoletano","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1128\/JVI.78.15.8301-8311.2004","article-title":"Dileucine and YXXL Motifs in the Cytoplasmic Tail of the Bovine Leukemia Virus Transmembrane Envelope Protein Affect Protein Expression on the Cell Surface","volume":"78","author":"Novakovic","year":"2004","journal-title":"J. Virol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/ijc.25458","article-title":"Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses","volume":"128","author":"Singh","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4049\/jimmunol.1900289","article-title":"Signaling Cascade through DC-ASGPR Induces Transcriptionally Active CREB for IL-10 Induction and Immune Regulation","volume":"203","author":"Gu","year":"2019","journal-title":"J. Immunol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1189\/jlb.1012520","article-title":"MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-\u03b1 secretion","volume":"94","author":"Bay","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V88.7.2549.bloodjournal8872549","article-title":"Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells","volume":"88","author":"Henschler","year":"1996","journal-title":"Blood"},{"key":"ref_287","doi-asserted-by":"crossref","unstructured":"Unutmaz, D., Zizzari, I.G., Martufi, P., Battisti, F., Rahimi, H., Caponnetto, S., Bellati, F., Nuti, M., Rughetti, A., and Napoletano, C. (2015). The Macrophage Galactose-Type C-Type Lectin (MGL) Modulates Regulatory T Cell Functions. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132617"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ni1390","article-title":"Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45","volume":"7","author":"Gringhuis","year":"2006","journal-title":"Nat. Immunol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12974-019-1522-4","article-title":"Macrophage galactose-type lectin (MGL) is induced on M2 microglia and participates in the resolution phase of autoimmune neuroinflammation","volume":"16","author":"Ilarregui","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.imbio.2014.10.002","article-title":"Novel insights into the immunomodulatory role of the dendritic cell and macrophage-expressed C-type lectin MGL","volume":"220","author":"Ilarregui","year":"2015","journal-title":"Immunobiology"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/j.1462-5822.2009.01370.x","article-title":"N-glycosylated proteins and distinct lipooligosaccharide glycoforms ofCampylobacter jejunitarget the human C-type lectin receptor MGL","volume":"11","author":"Bleumink","year":"2009","journal-title":"Cell. Microbiol."},{"key":"ref_292","doi-asserted-by":"crossref","unstructured":"Kremsreiter, S.M., Kroell, A.-S.H., Weinberger, K., and Boehm, H. (2021). Glycan\u2013Lectin Interactions in Cancer and Viral Infections and How to Disrupt Them. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910577"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.imbio.2014.09.013","article-title":"Signalling versatility following self and non-self sensing by myeloid C-type lectin receptors","volume":"220","author":"Iborra","year":"2015","journal-title":"Immunobiology"},{"key":"ref_294","doi-asserted-by":"crossref","unstructured":"Pedro, A.R.V., Lima, T., Fr\u00f3is-Martins, R., Leal, B., Ramos, I.C., Martins, E.G., Cabrita, A.R.J., Fonseca, A.J.M., Maia, M.R.G., and Vilanova, M. (2021). Dectin-1-Mediated Production of Pro-Inflammatory Cytokines Induced by Yeast \u03b2-Glucans in Bovine Monocytes. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.689879"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.apsb.2020.11.003","article-title":"Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.biomaterials.2017.04.043","article-title":"Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy","volume":"134","author":"Liu","year":"2017","journal-title":"Biomaterials"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/j.biomaterials.2013.01.079","article-title":"Galactosylated trimethyl chitosan\u2013cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejps.2018.10.009","article-title":"Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-\u0251 siRNA provide a novel strategy for the experimental treatment of ulcerative colitis","volume":"125","author":"Huang","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2018.08.021","article-title":"TNF\u03b1 gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis","volume":"287","author":"Xiao","year":"2018","journal-title":"J. Control Release"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/gut.2009.184556","article-title":"Targeting delivery of anti-TNF oligonucleotide into activated colonic macrophages protects against experimental colitis","volume":"59","author":"Zuo","year":"2009","journal-title":"Gut"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1021\/mp900081y","article-title":"Galactosylated LDL Nanoparticles: A Novel Targeting Delivery System to Deliver Antigen to Macrophages and Enhance Antigen Specific T Cell Responses","volume":"6","author":"Wu","year":"2009","journal-title":"Mol. Pharm."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jconrel.2011.11.013","article-title":"Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy","volume":"158","author":"Huang","year":"2012","journal-title":"J. Control Release"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.actbio.2014.09.019","article-title":"Galactosylated liposome as a dendritic cell-targeted mucosal vaccine for inducing protective anti-tumor immunity","volume":"11","author":"Jiang","year":"2015","journal-title":"Acta Biomater."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1016\/j.actbio.2012.11.007","article-title":"Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization","volume":"9","author":"Wang","year":"2013","journal-title":"Acta Biomater."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/10\/1308\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:09:02Z","timestamp":1760112542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/10\/1308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":304,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["pharmaceutics16101308"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics16101308","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]}}}